In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Cancer Type/Condition:  childhood atypical teratoid/rhabdoid tumor
Stage/Subtype:  childhood atypical teratoid/rhabdoid tumor
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under at the time of definitive surgery
Sponsor: NCI, Other
Protocol IDs: CDR0000592812, COG-ACNS0333, ACNS0333, NCT00653068
2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 3 to 21 at diagnosis
Sponsor: Other
Protocol IDs: SJMB03, SJCRH-SJMB03, NCT00085202
3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: CDR0000647587, COG-ADVL0912, ADVL0912, NCT00939770
4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 30
Sponsor: Other
Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398
5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 10-096, NCT01294670
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 05-122, MSKCC-05122, NCT00445965
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: CDR0000680512, COG-ADVL0921, ADVL0921, NCT01154816
8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 19 and under
Sponsor: Other
Protocol IDs: SNUCH-1201, NCT01535183
9.

Phase: Phase I
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 03-133, P30CA008748, MSKCC-03133, NCT00089245
10.

Phase: Phase I
Type: Treatment
Status: Active
Age: 2 to 21
Sponsor: Other
Protocol IDs: RADIANT, NCT01625351
11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 1 to 21
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLEE011X2102, NCT01747876
12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 3 at diagnosis
Sponsor: Other
Protocol IDs: SJYC07, SJCRH-SJYC07, NCT00602667
13.

Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: 2012-0823, NCT01737671
New Search